Nav: Home

Female sex hormone clue to fighting serious immune disease

June 10, 2016

London, United Kingdom, June 10, 2016: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2016) showed for the first time a beneficial effect of oestrogens in experimental models of skin fibrosis that are representative of the disease process in systemic sclerosis (SSc). These findings may explain the increased incidence of SSc in women after the menopause, the greater severity of SSc in men, and importantly open up the possibility of developing potential hormone therapies for this difficult-to-treat condition.

SSc (also known as scleroderma) is an autoimmune disease affecting multiple organs, which predominantly affects women (with a female-to-male ratio of up to 9:1). Skin thickening is a defining feature of SSc, with excessive production of proteins such as collagen by fibroblasts resulting in skin thickening.

Skin involvement may be mainly confined to the face and extremities; however, in some SSc patients, disease progression is very rapid, with skin thickening extending beyond the extremities, and earlier, more widespread fibrosis involving the internal organs. The extent of skin involvement in SSc correlates inversely with survival and is considered a valuable marker of overall disease severity.3 Currently, no therapy with an acceptable toxicity profile has proven to be effective in the treatment of SSc skin disease.

"Because of the clear sex bias in SSc, we decided to assess if blocking the action of oestrogens, (female hormones that decrease in menopause) plays a role in the development or vulnerability to this disease," explained Dr Jerome Avouac of the Paris Descartes University, Cochin Hospital, Paris, France.

The effect of oestrogen inhibition was evaluated in mouse models of skin fibrosis using two techniques. Firstly, in a population of mice in whom gene inactivation had knocked out the key receptor that responds to oestrogens, and secondly using tamoxifen which is a hormone therapy that blocks the action of oestrogen. Results showed that oestrogen inhibition consistently and significantly exacerbated the process of skin fibrosis.

In a second experiment, skin fibroblasts from SSc patients were stimulated with the cytokine that activates skin fibrosis (TGF-β) and then incubated with different concentrations of 17-?-oestradiol (a form of oestrogen) and/or tamoxifen to inhibit oestrogen. Measurements of the release of collagen from the fibroblasts, differentiation of these fibroblasts into myofibroblasts, and evidence of activation of the TGF-β pathway all confirmed that oestrogens significantly slow down fibrosis.

"Having confirmed that oestrogens indeed play a role in protecting against skin fibrosis in experimental models representative of SSc, the next step will be to begin investigating the potential role of hormone therapies as a treatment of SSc skin disease," Dr Avouac concluded.

Abstract Number: OP0304
-end-
NOTES TO EDITORS:

For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress

Press Office in the London Suite at ExCel London during EULAR 2016 or on:

Email: eularpressoffice@cohnwolfe.com

Onsite tel: +44 (0) 7725 915 492 / +44 (0) 7786 171 476

Twitter: @EULAR_Press

Youtube: Eular Pressoffice

About EULAR

The European League Against Rheumatism (EULAR) is an umbrella organisation which represents scientific societies, health professional associations and organisations for people with Rheumatic Musculoskeletal Diseases (RMD) throughout Europe.

EULAR aims to promote, stimulate and support the research, prevention, and treatment of RMD and the rehabilitation of those it affects.

EULAR underlines the importance of combating rheumatic diseases not only by medical means, but also through a wider context of care for rheumatic patients and a thorough understanding of their social and other needs. EULAR is supported in this mission by its 45 scientific member societies, 36 PARE (People with Arthritis/Rheumatism in Europe) organisations, 22 HPR (Health Professionals in Rheumatology) associations and 23 corporate members.

The EULAR Annual European Congress of Rheumatology is the foremost international medical meeting announcing the latest research on rheumatic and musculoskeletal diseases. EULAR 2016 is expected to attract over 14,000 delegates from around 120 countries. Most if not all professions working in the vast field of RMD will be represented.

To find out more about the activities of EULAR, visit: http://www.eular.org

References

1. EULAR 2016; London: Abstract OP0304

2. Gabrielli A, Avvedimento EV, Krieg T: Scleroderma. N Engl J Med. 2009, 360: 1989-2003

3. Krieg T, Takehara K: Skin disease: a cardinal feature of systemic sclerosis. Rheumatology (Oxford). 2009, 48: iii14-iii18

4. Postlethwaite AE, Harris LJ, Raza SH, Kodura S, Akhigbe T: Pharmacotherapy of systemic sclerosis. Expert Opin Pharmacother. 2010, 11: 789-806

European League Against Rheumatism

Related Fibroblasts Articles:

When healthy cells stimulate the migration of tumor cells
Estrogens act as a driving force of both healthy and cancerous mammary cell growth by binding to receptors that include GPER, which is generally located in cell membranes.
New understanding of chronic lung inflammatory diseases unfolding
Researchers studying chronic inflammation that can lead to the development of lung diseases such as asthma, pulmonary fibrosis, and cancer, are focusing on the role cytokines play in regulating the behavior of fibroblast cells and the extracellular matrix.
Scientists discover new mechanism that leads to inflammation in rheumatoid arthritis
New research findings published in the Journal of Leukocyte Biology, suggest that synovial CD4+ T cells that produce IL-21 contribute to joint inflammation by activating synovial fibroblasts in rheumatoid arthritis patients.
HIV hijacks common cells to spread infection
Scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF), together with collaborators in Europe, discovered that a common type of cell within the human reproductive and intestinal tracts assists HIV in infecting immune cells.
Fibroblasts could provide new target for treatment of rheumatoid arthritis
A study led by researchers at the University of Birmingham reveals the key role of different types of fibroblast cells in the development of rheumatoid arthritis, opening up a new avenue for research into treatment of the disease.
Study shows low-dose chemotherapy regimens could prevent tumor recurrence in some cancers
Conventional, high-dose chemotherapy treatments can cause the fibroblast cells surrounding tumors to secrete proteins that promote the tumors' recurrence in more aggressive forms, researchers have discovered.
Reason for pancreatic cancer's resistance to chemotherapy found
A pioneering University of Liverpool research team have published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy.
How the heart turns into bone
Connective tissue cells in the heart turn into bone-producing cells in response to injury, UCLA scientists report Nov.
New findings show promise for treatment of Graves' disease and other ocular disorders
A new class of therapies may be on the horizon for thyroid eye disease (TED) and other destructive scarring conditions.
Removing cellular bookmarks smooths the path to stem cells
In reading, a bookmark tells where you stopped. Cells use bookmarks too, specific proteins to help remember what collection of genes needs to be turned on again after cell division.

Related Fibroblasts Reading:

Fibroblast Growth Factors: Biology and Clinical Application: FGF Biology and Therapeutics
by MICHAEL SIMONS (Author)

Tumor-Associated Fibroblasts and their Matrix (The Tumor Microenvironment)
by Margareta M. Mueller (Editor), Norbert E. Fusenig (Editor)

Report of Workshop on the Fibroblast in Interstitial Lung Diseases
by Workshop on the Fibroblast in Interstitial Lung Diseases (Author)

DNA double-strand break repair is impaired in presenescent Syrian hamster fibroblasts
by Bandirma Press (Author)

Fibroblast Growth Factors
by Xiaokun Li (Author)

Fibroblast-like: Webster's Timeline History, 1957 - 2007
by Icon Group International (Author)

Replicative Cessation & DNA Damage in Human Fibroblast under Stress: A study to investigate the replicative cessation, morphology and DNA damage in human fibroblasts under stress conditions
by Sahar Khalil (Author), Gehad Hammouda (Author), Somaya Hosny (Author)

Fibroblast-derived matrix: Regulation of type I collagen synthesis: Recreating the in vivo micro-environment
by Kevin Dzobo (Author)

Fibroblast Growth Factor-23 as Novel Marker of Phosphate Homeostasis
by Noreen Abbas (Author), Aysha Habib Khan (Author)

Application of chitosan in culturing 3t3 fibroblast cell
by Toan Nguyen Van (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Dying Well
Is there a way to talk about death candidly, without fear ... and even with humor? How can we best prepare for it with those we love? This hour, TED speakers explore the beauty of life ... and death. Guests include lawyer Jason Rosenthal, humorist Emily Levine, banker and travel blogger Michelle Knox, mortician Caitlin Doughty, and entrepreneur Lux Narayan.
Now Playing: Science for the People

#492 Flint Water Crisis
This week we dig into the Flint water crisis: what happened, how it got so bad, what turned the tide, what's still left to do, and the mix of science, politics, and activism that are still needed to finish pulling Flint out of the crisis. We spend the hour with Dr Mona Hanna-Attisha, a physician, scientist, activist, the founder and director of the Pediatric Public Health Initiative, and author of the book "What the Eyes Don't See: A Story of Crisis, Resistance, and Hope in an American City".